ALSERES PHARMACEUTICALS INC /DE: key financial figures for fiscal year 2013 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2013)

$1.9M

Net Income/Loss (FY2013)

-$941.5K

Total Assets (FY2013)

$385.5K

Total Equity (FY2013)

-$10.7M

Cash Flows from Operating Activities (FY2013)

-$162.2M

Source: ALSERES PHARMACEUTICALS INC /DE 10-K filing (FY2013). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.